Shanghai Jewel Bioengineering Co.,Ltd

We focus on the design and production of high-end complex injection dispensing system. At the same time, we provide complete traceability documents that meet the requirements of FDA, EMA, WHO and GMP.

The term "terminal complex injection" refers to anti-cancer drug including a substance preparation (monoclonal antibody, vaccine, recombinant protein and insulin), a liquid product, liposome, drug loaded fat emulsion, sodium microspheres and long-acting microspheres, polypeptide injection, a new type of injection emulsion and other special preparations.

Worldwide, the demand is extremely high. Most of them have the advanced characteristics of modern drugs, such as novel administration, long-term, targeted and good compliance with the body, which are significant in improving the efficacy and quality of life. More and more drug R&D and manufacturing institutions, especially multinational pharmaceutical companies and top 50 pharmaceutical companies in China, are actively investing R & D and investment in the complex injection field.

Jewel is capable to provide customized formulation preparation equipment in accordance with the customer's technology, and provide the customer with pilot plant service to assist in the implementation of technology and bacteria correlation verification. The scope of service includes technology release, equipment design and manufacturing, process integration, system verification and technology verification.

Jewel provides reliable process system equipment to help customers get huge value-added income from completing the production process!